CompletedPhase 1NCT01533194
Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma
Studying Light chain deposition disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Craig Hofmeister, MDOhio State University Comprehensive Cancer Center
- Intervention
- Diagnostic Laboratory Biomarker Analysis(other)
- Enrollment
- 12 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2012 – 2015
Study locations (1)
- Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01533194 on ClinicalTrials.govOther trials for Light chain deposition disease
Additional recruiting or active studies for the same condition.